Labs / Assays & in vitro testing

AvenCell
Dresden, Germany · avencell.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
AvenCell is a clinical-stage biopharmaceutical company developing next-generation immunotherapies for hard-to-treat cancers. It focuses on engineered T-cell therapies, with operations in Watertown, Massachusetts, and offices in Dresden, Germany and Tokyo, Japan.
They take quote requests by email.
What they offer
Universal Switchable CAR platform
Develops switchable CAR-T cell therapies designed for controllable targeting of cancer antigens using soluble targeting modules.
Allogeneic platform
Develops allogeneic, switchable CAR-T cell products engineered to address limitations of current gene-edited allogeneic T-cell therapies.
Clinical-stage immunotherapy development
Advances autologous and allogeneic universal reprogrammable T-cell products focused initially on hard-to-treat cancers.
Clinical and strategic collaborations
Collaborates with partners on joint development of novel immunotherapies based on its platform technologies.
What they work on
- Modalities
- Antibody, Cell therapy, Gene editing
- Therapeutic areas
- hard-to-treat cancers, solid tumors, oncology
- Sites
- Watertown, MA, USA · Dresden, Germany · Tokyo, Japan
- Address
- 500 Forge Road Watertown, MA 02472 USA
Public records
Similar labs. CDI Labs, Minaris, PROGEN INC, 3C Therapeutics
Found in a contract services directory, the German GLP list (BfR). Listing built from avencell.com. Work here? Claim this listing.